Mann J. Being ‘Brave’: How Shire Pharmaceuticals nurtured its unique culture from a simple brand idea. J Brand Strat2013; 2(3): 236–244.
2.
MacKey T and Liang BA. Dangerous science: Online promotion of unproven stem cell therapies and global health risks. J Commercial Biotechnol2013; 19(4): 19–28.
3.
Kuo Y-S, Kuo T-K, Lu H-P and Minshall T. Exploring an effective model of new product development in medical devices: A knowledge cluster approach. Int J Technol Manage2013; 63(3/4): 295–312.
4.
Barrot C, Kuhlmann J and Popa A. Influence of personal communication networks on innovation adoption: Using multi-agent simulations to project the launch of an innovative medical device. Int J Innov Technol Manage2013; 10(5): 1–19.
5.
Sillup GP, Dehshal MH and Namini MT. Pharmaceutical companies and physicians: Assessing their relationship. Int J Healthcare Manage2013; 6(4): 276–280.
6.
Hsu C-S and Wu C-S. A dynamic game theoretic approach to Chinese pharmaceutical firms' international strategic alliance. Inno Manage Pol Pract2013; 5(3): 350–363.
